ClearPoint Neuro (CLPT) stock price, revenue, and financials

ClearPoint Neuro market cap is $444.1 m, and annual revenue was $11.22 m in FY 2019

$444.1 M

CLPT Mkt cap, 08-Feb-2021

$2.5 M

ClearPoint Neuro Revenue Q2, 2020
ClearPoint Neuro Gross profit (Q2, 2020)1.8 M
ClearPoint Neuro Gross profit margin (Q2, 2020), %74.1%
ClearPoint Neuro Net income (Q2, 2020)-1.7 M
ClearPoint Neuro EBIT (Q2, 2020)-1.5 M
ClearPoint Neuro Cash, 30-Jun-202016 M
ClearPoint Neuro EV429.3 M

ClearPoint Neuro Revenue

ClearPoint Neuro revenue was $11.22 m in FY, 2019

Embed Graph

ClearPoint Neuro Revenue Breakdown

Embed Graph

ClearPoint Neuro revenue breakdown by business segment: 9.1% from Service and Other and 90.9% from Product

ClearPoint Neuro Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.7m7.4m7.4m11.2m

Revenue growth, %

25%28%0%

Cost of goods sold

2.6m2.9m2.4m3.8m

Gross profit

3.1m4.5m4.9m7.4m

Gross profit Margin, %

54%61%67%66%

Sales and marketing expense

4.0m3.5m4.8m

R&D expense

2.6m2.8m2.3m2.9m

General and administrative expense

8.0m4.0m4.3m4.3m

Operating expense total

10.6m10.8m10.2m12.0m

EBIT

(7.5m)(6.3m)(5.2m)(4.6m)

EBIT margin, %

(130%)(86%)(71%)(41%)

Interest expense

1.1m872.9k980.4k

Interest income

8.8k

Net Income

(8.1m)(7.2m)(6.2m)(5.5m)

ClearPoint Neuro Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.3m9.3m3.1m5.7m

Accounts Receivable

865.9k949.4k1.2m1.1m

Prepaid Expenses

135.0k192.7k213.7k357.2k

Inventories

1.8m2.3m2.1m3.2m

Current Assets

6.1m12.7m6.7m10.4m

PP&E

328.2k267.7k377.7k447.2k

Total Assets

7.4m13.9m7.9m11.9m

Accounts Payable

1.5m759.4k500.9k965.8k

Short-term debt

2.0m113.5k

Current Liabilities

3.0m4.4m2.0m3.8m

Long-term debt

2.0m2.3m

Total Debt

2.0m2.0m2.5m

Total Liabilities

8.2m8.1m6.3m7.3m

Common Stock

36.2k106.9k110.2k152.4k

Additional Paid-in Capital

93.1m106.8m108.6m117.2m

Retained Earnings

(93.9m)(101.0m)(107.2m)(112.7m)

Total Equity

(756.1k)5.8m1.5m4.6m

Debt to Equity Ratio

-2.6 x0.3 x

Debt to Assets Ratio

0.3 x0.1 x

Financial Leverage

-9.8 x2.4 x5.2 x2.6 x

ClearPoint Neuro Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(8.1m)(7.2m)(6.2m)(5.5m)

Depreciation and Amortization

155.7k116.5k109.4k250.6k

Accounts Receivable

352.1k(83.5k)(284.5k)144.0k

Inventories

72.3k(469.9k)122.2k(1.0m)

Accounts Payable

178.4k(512.4k)(284.3k)1.2m

Cash From Operating Activities

(5.8m)(6.0m)(4.6m)(2.8m)

Purchases of PP&E

(101.0k)(26.8k)(63.5k)(10.2k)

Cash From Investing Activities

(101.0k)(26.8k)(63.5k)(160.2k)

Long-term Borrowings

(2.0m)(2.1m)

Cash From Financing Activities

3.8m12.0m(1.5m)5.6m

Net Change in Cash

(2.1m)6.0m(6.2m)2.6m

Interest Paid

976.3k348.5k210.7k316.6k

ClearPoint Neuro Ratios

USDFY, 2016

Revenue/Employee

174.2k

Debt/Equity

-2.6 x

Debt/Assets

0.3 x

Financial Leverage

-9.8 x

ClearPoint Neuro Operating Metrics

Nov, 2019

Industry Partners

3

Patent Applications

95

Patents Issued

95